PRESS RELEASE published on 09/25/2023 at 07:00, 1 year 1 month ago Kinarus Therapeutics has decided to file for bankruptcy
PRESS RELEASE published on 08/30/2023 at 18:00, 1 year 2 months ago Kinarus Therapeutics Group Reports First Half 2023 Financial Results
PRESS RELEASE published on 08/25/2023 at 18:00, 1 year 2 months ago Kinarus Therapeutics signed licensing agreement to extend cash for operations
PRESS RELEASE published on 07/12/2023 at 07:00, 1 year 4 months ago Kinarus Therapeutics Announces Personnel Changes
PRESS RELEASE published on 06/29/2023 at 18:00, 1 year 4 months ago Kinarus Therapeutics Shareholders Approve All Board Proposals at the 2023 Annual General Meeting
PRESS RELEASE published on 06/27/2023 at 07:00, 1 year 4 months ago Kinarus Therapeutics signed subordinated bridge loans to ensure further liquidity
PRESS RELEASE published on 06/02/2023 at 08:00, 1 year 5 months ago Kinarus Therapeutics Publishes Invitation to the 2023 Annual General Meeting
PRESS RELEASE published on 05/31/2023 at 07:00, 1 year 5 months ago Kinarus Therapeutics Group Reports 2022 Annual Results
PRESS RELEASE published on 05/11/2023 at 07:00, 1 year 6 months ago Kinarus Therapeutics signed CHF1.5 million convertible loan agreement with ChaoDian (Hangzhou) Investment Management
PRESS RELEASE published on 05/05/2023 at 07:00, 1 year 6 months ago Kinarus Therapeutics Reports Key Unaudited Full Year 2022 Figures
Published on 11/21/2024 at 13:00, 31 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 31 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 31 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 13:00, 31 minutes ago Nextech3D.ai Spin-Out Rebrands as FOTOgpt.ai to Usher in a New Era of AI-Powered Photography
Published on 11/21/2024 at 13:00, 31 minutes ago Clean Air Metals Announces Positive Results from Innovative Seismic Survey at the Escape Deposit Down-Plunge Extension
Published on 11/21/2024 at 12:35, 56 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 16 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 6 hours 33 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 11 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 19 hours 46 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 19 hours 46 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 5 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo